• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>MacDermid Incorporated

MacDermid Incorporated

  1. All
  2. Morningstar Articles
  3. 3rd Party
  4. Investing
  1. Seattle Genetics Presents Phase 1b Data from Vadastuximab Talirine (SGN-CD33A; 33A) in Combination with Standard of Care in Frontline Acute Myeloid Leukemia at ASH Annual Meeting

    Seattle Genetics Presents Phase 1b Data from Vadastuximab Talirine (SGN-CD33A; 33A) in Combination with Standard of Care in Frontline Acute Myeloid Leukemia at ASH Annual Meeting

  2. UPDATE: Should you take a lump sum, an annuity, or a mix of both when you retire?

    UPDATE: Should you take a lump sum, an annuity, or a mix of both when you retire?

  3. Roth Conversion of Aftertax Money

    Natalie Choate answers reader questions about Roth conversion rules as they relate to inherited IRAs and profit-sharing plans.

  4. RMD Surprises!

    Little-known RMD issues do pop up every once and awhile.

  5. The New Tax Law and IRAs

    The 2010 "Tax Relief Act" affects planning for our clients' retirement benefits in three ways.

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.